GV 2015 L.P. 13D and 13G filings for Spero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 4:37 pm Sale |
2020-12-31 | 13G | Spero Therapeutics, Inc. SPRO |
GV 2015 L.P. | 889,979 3.270% |
-222,494 (-20.00%) |
Filing |